Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - rna+-+ribonucleic+acid
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Therapeutic Intervention for ALS and Dementia
NU 2021-058 INVENTORS Evangelos Kiskinis* Juan Alberto Ortega Cano Marco Boccitto SHORT DESCRIPTION Design of an RNA-based oligonucleotide that protects from dipeptide repeat protein toxicity for the treatment of ALS and FTD. BACKGROUND Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating neurodegenerative diseases...
Published: 8/5/2025
|
Inventor(s):
Keywords(s):
ALS - Amyotrophic Lateral Sclerosis
,
CNS - Central Nervous System
,
DPR - Dipeptide Repeat Proteins
,
FTD - Frontotemporal Dementia
,
Neurodegenerative disease
,
Neurology
,
RNA - Ribonucleic Acid
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Enhancing Gene Silencing by RNAi
NU 2005-063, NU 2005-064, and NU 2006-182 InventorsRichard Carthew* Dinari Harris Young Sik Lee Short DescriptionNovel strategy to improve gene silencing by RNAi for development of therapeutics AbstractRNAi has been proposed as a therapeutic strategy for disorders characterized by aberrant gene overexpression (cancer, macular degeneration etc.) as well...
Published: 8/5/2025
|
Inventor(s):
Keywords(s):
Biologic
,
Gene therapy
,
Infectious disease
,
Research tool
,
RNA - Ribonucleic Acid
,
Therapeutics
,
Vector/Plasmid
Category(s):
Life Sciences > Therapeutics
A Novel RNA Therapeutic Candidate for Fibrotic Diseases
LU 2015-101 InventorsAnn Harris*Lindsay Stolzenburg Short DescriptionA microRNA drug candidate that treats fibrotic diseases through the repression of TGF-β receptor expression. AbstractNorthwestern researchers have identified an innovative therapeutic strategy to treat acute and chronic fibrotic diseases. Progression of fibrosis involves repeated...
Published: 8/5/2025
|
Inventor(s):
Keywords(s):
Biologic
,
Inflammation
,
RNA - Ribonucleic Acid
,
Therapeutics
Category(s):
Life Sciences > Therapeutics